Evaluation of fungal and bacterial contaminations of patient-used ocular drops

Medical Mycology

Volumn 46, Issue 1, 2008, Pages 17-21

  Feghhi, Mostafa ^a   Mahmoudabadi, Ali Zarei ^b   Mehdinejad, Manijeh ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bacteria; Eye drop product; Fungi; Microbial contamination; Saprophyte

Indexed keywords

AGENTS ACTING ON THE EYE; AMIKACIN; ATROPINE; BETAMETHASONE; CEFAZOLIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; EYE DROPS; GENTAMICIN; HOMATROPINE; NAPHAZOLINE; PHENYLEPHRINE; PILOCARPINE; SULFACETAMIDE; TETRACAINE; TIMOLOL; TROPICAMIDE; VANCOMYCIN;

ACREMONIUM; AIRBORNE BACTERIUM; AIRBORNE FUNGUS; ALTERNARIA; AMBIENT AIR; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERIUM CONTAMINATION; CANDIDA ALBICANS; CLADOSPORIUM; CONTROLLED STUDY; DRUG CONTAMINATION; DRUG DELIVERY SYSTEM; DRUG PACKAGING; DRUG USE; FUNGAL CONTAMINATION; GLIOCLADIUM; INCIDENCE; IRAN; MICROBIAL IDENTIFICATION; NOCARDIA; NONHUMAN; PENICILLIUM; RANDOMIZATION; RHODOTORULA; RISK ASSESSMENT; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA; DRUG CONTAMINATION; DRUG PACKAGING; DRUG STORAGE; FUNGI; HUMANS; IRAN; OPHTHALMIC SOLUTIONS; TIME FACTORS;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 39749143246     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701487979     Document Type: Article

References (17)

1. Menzies, D. and Bourbeau, J. (1997) Building-related illnesses. N Engl J Med, 337, pp. 1524-1531.
2. Stone, V. (2000) Environmental air pollution. Am J Respir Crit Care Med, 162, pp. S44-S47.
3. Nunes, ZG, Martins, AS and Altoe, AL (2005) Indoor air microbiological evaluation of offices, hospitals, industries, and shopping centres. Mem Inst Oswaldo Cruz, 100, pp. 351-357.
4. Martins-Diniz, JN, da Silva, RA, Miranda, ET and Mendes-Giannini, MJ. (2005) Monitoring of airborne fungus and yeast species in a hospital unit. Rev Saude Publica, 39, pp. 398-405.
5. Micallef, C. and Cuschieri, P. (2001) Ocular infections due to contaminated solutions. Ophthalmologica, 215, pp. 337-350.
6. Rippon, JW. (1988) Medical Mycology. The Pathogenic Fungi and Actinomycetes, pp. 666-668. WB Saunders Co, Philadelphia
7. Thomas, PA. (2003) Current perspectives on ophthalmic mycoses. Clin Microbiol Rev, 16, pp. 730-797.
8. Livingstone, DJ, Hanlon, GW and Dyke, S. (1998) Evaluation of an extended period of use for preserved eye drops in hospital practice. Br J Ophthalmol, 82, pp. 473-475.
9. Fazeli, MR, Nejad, H Behesht, Mehrgan, H. and Elahian, L. (2004) Microbial contamination of preserved ophthalmic drops in outpatients: possibility of extended period of use. Daru, 12, pp. 151-155.
10. Tasli, H. and Cosar, G. (2001) Microbial contamination of eye drops. Cent Eur J Public Health, 9, pp. 162-164.
11. Mahmoudabadi, A Zarei, Drucker, DB, Mandall, N., O'Brien, K. and Theaker, E. (2000) Isolation and identification of Candida species from the oral cavity using CHROMagar Candida. IBJ, 4, pp. 57-61.
12. Mahmoudabadi, A. Zarei (2003) Medical Mycology, pp. 129-189. Vasef Co, Iran
13. Larsen, HS. (2000) Laboratory identification of significant isolates. Textbook of Diagnostic Microbiology, pp. 330-399. WB Saunders Company, Philadelphia
14. Sauer, R., Bluthner, K. and Seitz, B. (2004) Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Ophthalmologe, 101, pp. 705-709.
15. Hovding, G. and Sjursen, H. (1982) Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles. Acta Ophthalmol (Copenh), 60, pp. 213-222.
16. Schein, OD, Hibberd, PL, Starck, T., Baker, AS and Kenyon, KR. (1992) Microbial contamination of in-use ocular medications. Arch Ophthalmol, 110, pp. 82-85.
17. Rahman, MQ, Tejwani, D., Wilson, JA, Butcher, I. and Ramaesh, K. (2006) Microbial contamination of preservative free eye drops in multiple application containers. Br J Ophthalmol, 90, pp. 139-141.